• Home
  • Search
  • Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends
  • Cite Icon44
  • https://doi.org/10.1001/jamainternmed.2024.7178Copy DOI Icon

Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Increasing rates of sexually transmitted infections (STIs) have been associated with rises in serious morbidity. While doxycycline postexposure prophylaxis (doxyPEP), a strategy in which individuals take doxycycline, 200 mg, after condomless sex to prevent bacterial STIs, has been shown to be efficacious in randomized clinical trials, doxyPEP's potential effect on population-level STI incidence is unknown. To assess the association of citywide doxyPEP guideline release with reported chlamydia, gonorrhea, and early syphilis cases in men who have sex with men (MSM) and in transgender women in San Francisco, California. This population-level interrupted time series analysis of reported San Francisco STI cases measured monthly cases of chlamydia, gonorrhea, and early syphilis prior to (July 2021-October 2022) and after (November 2022-November 2023) release of citywide doxyPEP guidelines in October 2022. All reported chlamydia, gonorrhea, and early syphilis cases among MSM and transgender women in San Francisco during the period of analysis were included. Data were analyzed November 2023 to July 2024. Release of doxyPEP citywide guidelines. The primary outcome was the percentage change between projected and observed chlamydia, gonorrhea, and early syphilis cases in the 13-month postexposure period. Citywide, there were 6694 cases of chlamydia, 9603 cases of gonorrhea, and 2121 cases of early syphilis among MSM and transgender women during the analytic period. STI cases among MSM and transgender women decreased significantly compared with model projections for chlamydia (-6.58% per month; 95% CI, -7.99% to -5.16%) and early syphilis (-2.68% per month; 95% CI, -3.75% to -1.60%) after doxyPEP implementation. By the end of the 13-month postperiod in November 2023, chlamydia and early syphilis cases decreased -49.64% (95% CI, -59.05% to -38.06%) and -51.39% (95% CI, -58.21% to -43.46%), respectively, compared with projected cases. There was a significant increase in monthly gonorrhea cases compared with projections (1.77% per month; 95% CI, 0.87% to 2.67%). This study suggests that San Francisco's doxyPEP guideline release was associated with decreases in reported cases of chlamydia and early syphilis, but not gonorrhea, among MSM and transgender women in San Francisco. Further analyses are needed to assess whether declines are sustained and monitor for adverse consequences, including antimicrobial resistance. Supporting doxyPEP implementation for MSM and transgender women at risk for STIs could have a significant impact on the nationwide STI epidemic.

Similar Papers

Sexually Transmitted Infections: Impact and Cost-Effectiveness of Prevention

  • Nov 03, 2017
  • Harrell W Chesson +2
  • Research Article
  • Citations28

Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension.

  • Aug 01, 2025
  • The Lancet. Infectious diseases
  • Anne F Luetkemeyer +19
  • Research Article
  • Citations22

Emergency department-based surveillance for syphilis during an outbreak in Philadelphia.

  • Aug 01, 1993
  • Annals of emergency medicine
  • Jonathan R Hibbs +3
  • PDF
  • Research Article
  • Citations43

Identity, stigma, and HIV risk among transgender women: a qualitative study in Jiangsu Province, China

  • Dec 01, 2019
  • Infectious Diseases of Poverty
  • Zi-Han Yan +6
  • Research Article
  • Citations5

Sexual Behavior and Sexually Transmitted Infection Outcomes Among Men Who Have Sex With Men and Transgender Women Participating in a Study of the Timing of Antiretroviral Therapy in Lima, Peru.

  • Dec 01, 2020
  • Sexually Transmitted Diseases
  • Michalina A Montaño +7
  • Research Article
  • Citations54

Risk for HIV and unprotected sexual behavior in male primary partners of transgender women.

  • May 21, 2011
  • Archives of sexual behavior
  • Don Operario +3
  • Research Article

Herpes, Syphilis, and Human Immunodeficiency Virus Coinfection Among Transgender Women in Central Brazil.

  • Sep 30, 2022
  • Sexually Transmitted Diseases
  • Bruno Vinícius Diniz E Silva +11
  • Abstract

P349 Demographic and behavioural characteristics of patients diagnosed with early versus late syphilis at Western Sydney Sexual Health Centre, 2015–2019

  • Jul 01, 2021
  • Sexually Transmitted Infections
  • Y Hughes +3
  • Research Article
  • Citations1

Evaluation of a novel comprehensive sexual health e-testing pathway to inform state-wide roll out in new South wales, Australia

  • Aug 25, 2025
  • BMC Infectious Diseases
  • Prital Patel +9
  • Research Article

Analysis on results of syphilis serological test of 4 162 serum specimens in STD clinics

  • Jan 10, 2018
  • Central Plains Medical Journal
  • Jiangzhou Yan +6
  • Abstract

P778 HIV infection in transgender women from a region far from the epicenter of the HIV epidemic in brazil – preliminary results

  • Jul 01, 2019
  • Sexually Transmitted Infections
  • Sheila Teles +11
  • PDF
  • Discussion
  • Citations24

Similar, but different: drivers of the disproportionate HIV and sexually transmitted infection burden of key populations

  • Aug 01, 2019
  • Journal of the International AIDS Society
  • Kenneth H Mayer +1
  • PDF
  • Research Article
  • Citations4

Doxycycline post-exposure prophylaxis for sexually transmitted infections impacts the gut antimicrobial resistome

  • Apr 17, 2024
  • Research Square
  • Charles Langelier +14
  • Abstract

Is it time to use nucleic acid amplification tests for identification of persons with sexually transmitted infections?

  • Dec 01, 2020
  • International Journal of Infectious Diseases
  • L Tobin +7
  • Supplementary Content
  • Citations57

The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen

  • Sep 30, 2005
  • Sexually Transmitted Infections
  • S T Sadiq
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.